PGNY · NASDAQ
Progyny (PGNY) Stock Price & Fundamentals
Progyny (PGNY) closed at $387.28 on Oct 9, 2026, down 1.00% from the previous close of $391.21.
Share price, past year
1Y +7.59%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $387.28 |
| Sep 30, 2026 | $383.51 |
| Aug 31, 2026 | $374.72 |
| Jul 31, 2026 | $378.35 |
| Jun 30, 2026 | $369.39 |
| May 29, 2026 | $354.01 |
| Apr 30, 2026 | $373.82 |
| Mar 31, 2026 | $386.57 |
| Feb 27, 2026 | $405.33 |
| Jan 30, 2026 | $392.83 |
| Dec 31, 2025 | $388.87 |
| Nov 28, 2025 | $389.63 |
| Oct 31, 2025 | $357.89 |
Key statistics
- Market cap
- $29.97B
- P/E (TTM)
- 421.0
- EPS (TTM)
- $0.92
- Revenue (TTM)
- $1.31B
- Net income (TTM)
- $78.63M
- Shares outstanding
- 77.4M
- Dividend yield
- —
- 52-week range
- $350.74 – $409.57
Progyny's market cap is $29.97B, based on a share price of $387.28 and 77.4M shares outstanding as of Jun 30, 2026.
Financials
Progyny reported revenue of $1.29B for fiscal 2025, up 10.40% from fiscal 2024.
Progyny earned net income of $58.52M in fiscal 2025, a net margin of 4.5%.
Fiscal 2025 revenue was the highest in the 9 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $1.29B | +10.4% | $58.52M | 4.5% | $0.65 | $191.78M |
| FY2024ended Dec 31, 2024 | $1.17B | +7.2% | $54.34M | 4.7% | $0.57 | $173.70M |
| FY2023ended Dec 31, 2023 | $1.09B | +38.3% | $62.04M | 5.7% | $0.62 | $185.17M |
| FY2022ended Dec 31, 2022 | $786.91M | +57.2% | $30.36M | 3.9% | $0.30 | $77.15M |
| FY2021ended Dec 31, 2021 | $500.62M | +45.2% | $65.77M | 13.1% | $0.66 | $23.91M |
| FY2020ended Dec 31, 2020 | $344.86M | +50.2% | $46.46M | 13.5% | $0.47 | $35.17M |
| FY2019ended Dec 31, 2019 | $229.68M | +117.9% | −$8.57M | −3.7% | −$0.41 | −$4.49M |
| FY2018ended Dec 31, 2018 | $105.40M | +116.9% | $661.00K | 0.6% | $0.04 | $1.69M |
| FY2017ended Dec 31, 2017 | $48.58M | — | −$12.45M | −25.6% | −$2.37 | −$10.09M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $350.51M | $28.05M | $0.34 |
| Q1 FY2026ended Mar 31, 2026 | $328.50M | $24.23M | $0.29 |
| Q4 FY2025ended Dec 31, 2025 | $318.40M | $12.49M | $0.14 |
| Q3 FY2025ended Sep 30, 2025 | $313.35M | $13.86M | $0.15 |
| Q2 FY2025ended Jun 30, 2025 | $332.87M | $17.11M | $0.19 |
| Q1 FY2025ended Mar 31, 2025 | $324.04M | $15.06M | $0.17 |
| Q4 FY2024ended Dec 31, 2024 | $298.43M | $10.53M | $0.12 |
| Q3 FY2024ended Sep 30, 2024 | $286.63M | $10.42M | $0.11 |
Company profile
- Name
- Progyny, Inc.
- Ticker
- PGNY
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 1359 Broadway, 2nd Floor, New York, NY 10018
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001551306
Recent SEC filings
- Aug 7, 2026
- Aug 6, 2026
- May 27, 2026
- May 26, 2026
- May 8, 2026
- May 7, 2026
- Mar 13, 2026
- Feb 27, 2026
Frequently asked questions
What is Progyny's stock price?
Progyny (PGNY) closed at $387.28 on Oct 9, 2026, down 1.00% from the previous close of $391.21.
What is Progyny's market cap?
Progyny's market cap is $29.97B, based on a share price of $387.28 and 77.4M shares outstanding as of Jun 30, 2026.
How much revenue does Progyny make?
Progyny reported revenue of $1.29B for fiscal 2025, up 10.40% from fiscal 2024.
What is PGNY's P/E ratio?
Progyny's price-to-earnings ratio is 421.0, based on trailing twelve-month diluted EPS of $0.92.
Does Progyny pay a dividend?
Progyny's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Progyny, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures